Viking Therapeutics (VKTX) Misses Q2 EPS by 13c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance